Michael Glantz
Michael Glantz
Penn State School of Medicine
Verified email at
Cited by
Cited by
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
WKA Yung, RE Albright, J Olson, R Fredericks, K Fink, MD Prados, ...
British journal of cancer 83 (5), 588-593, 2000
Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors
MJ Glantz, BF Cole, PA Forsyth, LD Recht, PY Wen, MC Chamberlain, ...
Neurology 54 (10), 1886-93, 2000
Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis
TJ Brown, MC Brennan, M Li, EW Church, NJ Brandmeir, KL Rakszawski, ...
JAMA oncology 2 (11), 1460-1469, 2016
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors
MJ Glantz, KA Jaeckle, MC Chamberlain, S Phuphanich, L Recht, ...
Clinical cancer research 5 (11), 3394-3402, 1999
Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme
DA Reardon, KL Fink, T Mikkelsen, TF Cloughesy, A O'Neill, S Plotkin, ...
Journal of clinical oncology 26 (34), 5610-5617, 2008
Cerebrospinal fluid cytology in patients with cancer: minimizing false‐negative results
MJ Glantz, BF Cole, LK Glantz, J Cobb, P Mills, A Lekos, BC Walters, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 1998
Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis
MJ Glantz, S LaFollette, KA Jaeckle, W Shapiro, L Swinnen, JR Rozental, ...
Journal of Clinical Oncology 17 (10), 3110-3116, 1999
Anti‐Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer
FA Luque, HM Furneaux, R Ferziger, MK Rosenblum, SH Wray, ...
Annals of Neurology: Official Journal of the American Neurological …, 1991
Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma
MC Chamberlain, MJ Glantz, L Chalmers, A Van Horn, AE Sloan
Journal of neuro-oncology 82, 81-83, 2007
Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis
M Yin, M Joshi, RP Meijer, M Glantz, S Holder, HA Harvey, M Kaag, ...
The oncologist 21 (6), 708-715, 2016
Treatment of radiation‐induced nervous system injury with heparin and warfarin
MJ Glantz, PC Burger, AH Friedman, RA Radtke, EW Massey, SC Schold
Neurology 44 (11), 2020-2020, 1994
High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?
MJ Glantz, BF Cole, L Recht, W Akerley, P Mills, S Saris, F Hochberg, ...
Journal of Clinical Oncology 16 (4), 1561-1567, 1998
Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression
PP Yee, Y Wei, SY Kim, T Lu, SY Chih, C Lawson, M Tang, Z Liu, ...
Nature communications 11 (1), 5424, 2020
A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors
MJ Glantz, BF Cole, MH Friedberg, E Lathi, H Choy, K Furie, W Akerley, ...
Neurology 46 (4), 985-991, 1996
Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment
MC Chamberlain, M Glantz, MD Groves, WH Wilson
Seminars in oncology 36, S35-S45, 2009
Recurrent meningioma: salvage therapy with long-acting somatostatin analogue
MC Chamberlain, MJ Glantz, CE Fadul
Neurology 69 (10), 969-973, 2007
Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography
MJ Glantz, JM Hoffman, RE Coleman, AH Friedman, MW Hanson, ...
Annals of neurology 29 (4), 347-355, 1991
Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid‐flow status
MJ Glantz, WA Hall, BF Cole, BS Chozick, CM Shannon, L Wahlberg, ...
Cancer 75 (12), 2919-2931, 1995
A randomized double-blind placebo-controlled phase II trial of dendritic cell vaccine ICT-107 in newly diagnosed patients with glioblastoma
PY Wen, DA Reardon, TS Armstrong, S Phuphanich, RD Aiken, ...
Clinical Cancer Research 25 (19), 5799-5807, 2019
Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas
MJ Glantz, PC Burger, JE Herndon, AH Friedman, JG Cairncross, NA Vick, ...
Neurology 41 (11), 1741-1741, 1991
The system can't perform the operation now. Try again later.
Articles 1–20